Deutsche Bank Ag\ Avenue Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$2.41 - $7.11 $10,449 - $30,828	-4,336 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$4.7 - $7.17 $1,931 - $2,946	-411 Reduced 8.66%	4,336 $26,000
Q4 2020 Feb 16, 2021	BUY	$2.95 - $11.04 $4,000 - $14,970	1,356 Added 39.99%	4,747 $28,000
Q3 2020 Nov 12, 2020	BUY	$9.37 - $12.06 $3,035 - $3,907	324 Added 10.56%	3,391 $37,000
Q2 2020 Aug 13, 2020	BUY	$8.29 - $11.47 $25,425 - $35,178	3,067 New	3,067 $33,000
Q1 2020 May 14, 2020	SELL	$6.44 - $11.32 $470 - $826	-73 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.26 - $9.6 $3,597 - $6,566	-684 Reduced 90.36%	73 $0
Q3 2019 Nov 14, 2019	SELL	$5.58 - $6.3 $33,781 - $38,140	-6,054 Reduced 88.89%	757 $4,000
Q2 2019 Aug 14, 2019	SELL	$4.33 - $6.54 $17,307 - $26,140	-3,997 Reduced 36.98%	6,811 $42,000
Q1 2019 May 15, 2019	BUY	$4.75 - $6.59 $51,338 - $71,224	10,808 New	10,808 $51,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.